Zealand Pharma A/S 2016 SR
The report covers Zealand Pharma's CSR activities for the fiscal year 2016, focusing on its transition toward becoming a fully integrated biotechnology company. Key highlights include maintaining high employee satisfaction at 96% and achieving 33% female representation on the Board of Directors. The company emphasized its commitment to the 3Rs in animal welfare and updated its Quality Manual to support late-stage development of proprietary peptides. Additionally, Zealand continued its community engagement through on-the-job training for refugees and collaborations with patient organizations.
Company: Zealand Pharma A/S
Sector: Manufacturing
Country: Denmark
Year: 2016
Type: SR
Pages: 11
Back to company
Zealand Pharma A/S
Corporate Social Responsibility Report
The report covers Zealand Pharma's CSR activities for the fiscal year 2016, focusing on its transition toward becoming a fully integrated biotechnology company. Key highlights include maintaining high employee satisfaction at 96% and achieving 33% female representation on the Board of Directors. The company emphasized its commitment to the 3Rs in animal welfare and updated its Quality Manual to support late-stage development of proprietary peptides. Additionally, Zealand continued its community engagement through on-the-job training for refugees and collaborations with patient organizations.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Women in Management
Employees